ArticleCJC open2024

Cardiac Safety of Ozanimod Use, a Novel Sphingosine-1-Phosphate Receptor Ligand, in COVID-19 Patients Requiring Oxygen: Secondary Analysis of the COZI Randomized Clinical Trial.

Guillaume Domain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.